...
search icon
fbio-img

Fortress Biotech Inc Share Price

FBIO
NAQ
$3.61
+$0.12
(3.44%)
1D
Industry: Biotechnology Sector: Health Care

Fortress Biotech Inc Analyst Forecast

Fortress Biotech Inc Share Price Chart

Fortress Biotech Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$112.05M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
270.68K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.42
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.33 L
$4.53 H
$3.61

About Fortress Biotech Inc, Common Stock

Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe recalcitrant nodular acne; Amzeeq, a topical formulation of minocycline for inflammatory lesions of non-nodular moderate to severe acne vulgaris; Zilxi for inflammatory lesions of rosacea; Exelderm, an antifungal cream and solution for topical use; Targadox, an oral doxycycline drug for therapy for severe acne; and Luxamend, a water-based emulsion to provide a moist healing environment for superficial wounds, minor cuts or scrapes, dermal ulcers, donor sites, sunburns, and radiation dermatitis. It also develops intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for Menkes disease; UNLOXCYT for metastatic cutaneous squamous cell carcinoma; Olafertinib for EGFR mutation-positive NSCLC; CAEL-101, a monoclonal antibody for amyloid light chain amyloidosis; and Triplex, a cytomegalovirus vaccine. In addition, the company's early-stage product candidates include Dotinurad for gout; MB-101 for glioblastoma; MB-108 for recurrent GBM; MB-109 for refractory glioblastoma and anaplastic astrocytoma; MB-106 for B-cell non-hodgkin lymphoma; AJ201, an androgen receptor degradation enhancer; and BAER-101, a positive allosteric modulator. Further, its preclinical product candidates comprise AAV-ATP7A and AVTS-001 gene therapies; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; and oligonucleotide platform. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida. more

Industry: BiotechnologySector: Health Care

Fortress Biotech Inc Stock Returns

Time FrameFBIOSectorS&P500
1-Week Return10.4%-0.03%-1.38%
1-Month Return-7.44%0.59%-1.81%
3-Month Return44.98%3.23%1.38%
6-Month Return87.05%18.29%5.68%
1-Year Return105.11%7.71%11.74%
3-Year Return-65.62%18.03%65.15%
5-Year Return-37.65%35.78%73.68%
10-Year Return-17.01%140.42%260.03%

Fortress Biotech Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue45.60M68.79M75.74M84.51M57.67M[{"date":"2020-12-31","value":53.96,"profit":true},{"date":"2021-12-31","value":81.4,"profit":true},{"date":"2022-12-31","value":89.62,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":68.24,"profit":true}]
Cost of Revenue14.59M32.08M30.77M22.89M20.88M[{"date":"2020-12-31","value":45.49,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.92,"profit":true},{"date":"2023-12-31","value":71.35,"profit":true},{"date":"2024-12-31","value":65.08,"profit":true}]
Gross Profit31.00M36.71M44.97M61.62M36.80M[{"date":"2020-12-31","value":50.32,"profit":true},{"date":"2021-12-31","value":59.57,"profit":true},{"date":"2022-12-31","value":72.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":59.71,"profit":true}]
Gross Margin67.99%53.36%59.37%72.91%63.80%[{"date":"2020-12-31","value":93.26,"profit":true},{"date":"2021-12-31","value":73.18,"profit":true},{"date":"2022-12-31","value":81.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":87.5,"profit":true}]
Operating Expenses125.28M225.25M248.53M203.96M147.18M[{"date":"2020-12-31","value":50.41,"profit":true},{"date":"2021-12-31","value":90.63,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.07,"profit":true},{"date":"2024-12-31","value":59.22,"profit":true}]
Operating Income(94.27M)(188.54M)(203.56M)(142.34M)(110.38M)[{"date":"2020-12-31","value":-9427000000,"profit":false},{"date":"2021-12-31","value":-18854100000,"profit":false},{"date":"2022-12-31","value":-20356400000,"profit":false},{"date":"2023-12-31","value":-14234200000,"profit":false},{"date":"2024-12-31","value":-11037900000,"profit":false}]
Total Non-Operating Income/Expense(22.39M)9.53M(22.14M)(26.31M)(21.01M)[{"date":"2020-12-31","value":-234.94,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-232.39,"profit":false},{"date":"2023-12-31","value":-276.09,"profit":false},{"date":"2024-12-31","value":-220.46,"profit":false}]
Pre-Tax Income(102.85M)(164.35M)(213.46M)(153.63M)(120.54M)[{"date":"2020-12-31","value":-10284900000,"profit":false},{"date":"2021-12-31","value":-16435300000,"profit":false},{"date":"2022-12-31","value":-21346400000,"profit":false},{"date":"2023-12-31","value":-15363300000,"profit":false},{"date":"2024-12-31","value":-12054300000,"profit":false}]
Income Taxes136.00K473.00K449.00K521.00K312.00K[{"date":"2020-12-31","value":26.1,"profit":true},{"date":"2021-12-31","value":90.79,"profit":true},{"date":"2022-12-31","value":86.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":59.88,"profit":true}]
Income After Taxes(102.98M)(164.83M)(213.91M)(154.15M)(120.86M)[{"date":"2020-12-31","value":-10298500000,"profit":false},{"date":"2021-12-31","value":-16482600000,"profit":false},{"date":"2022-12-31","value":-21391300000,"profit":false},{"date":"2023-12-31","value":-15415400000,"profit":false},{"date":"2024-12-31","value":-12085500000,"profit":false}]
Income From Continuous Operations(102.98M)(164.83M)(213.91M)(182.62M)(120.86M)[{"date":"2020-12-31","value":-10298500000,"profit":false},{"date":"2021-12-31","value":-16482600000,"profit":false},{"date":"2022-12-31","value":-21391300000,"profit":false},{"date":"2023-12-31","value":-18261500000,"profit":false},{"date":"2024-12-31","value":-12085500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(46.53M)(64.70M)(86.58M)(60.64M)(46.00M)[{"date":"2020-12-31","value":-4652600000,"profit":false},{"date":"2021-12-31","value":-6470300000,"profit":false},{"date":"2022-12-31","value":-8657500000,"profit":false},{"date":"2023-12-31","value":-6063700000,"profit":false},{"date":"2024-12-31","value":-4599700000,"profit":false}]
EPS (Diluted)(0.63)(0.92)(0.97)(2.67)(2.82)[{"date":"2020-12-31","value":-63,"profit":false},{"date":"2021-12-31","value":-92,"profit":false},{"date":"2022-12-31","value":-97,"profit":false},{"date":"2023-12-31","value":-267,"profit":false},{"date":"2024-12-31","value":-281.93,"profit":false}]

Fortress Biotech Inc Ratios

Fortress Biotech Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

FBIO
Cash Ratio 1.59
Current Ratio 2.19
Quick Ratio 1.97

Fortress Biotech Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

FBIO
ROA (LTM) -34.25%
ROE (LTM) -205.29%

Fortress Biotech Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

FBIO
Debt Ratio Lower is generally better. Negative is bad. 0.64
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.31

Fortress Biotech Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

FBIO
Trailing PE NM
Forward PE 344.83
P/S (TTM) 1.74
P/B 1.94
Price/FCF NM
EV/R 1.45
EV/Ebitda NM
PEG NM

FAQs

What is Fortress Biotech Inc share price today?

Fortress Biotech Inc (FBIO) share price today is $3.61

Can Indians buy Fortress Biotech Inc shares?

Yes, Indians can buy shares of Fortress Biotech Inc (FBIO) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in FBIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Fortress Biotech Inc be purchased?

Yes, you can purchase fractional shares of Fortress Biotech Inc (FBIO) via the Vested app. You can start investing in Fortress Biotech Inc (FBIO) with a minimum investment of $1.

How to invest in Fortress Biotech Inc shares from India?

You can invest in shares of Fortress Biotech Inc (FBIO) via Vested in three simple steps:

  • Click on Sign Up or Invest in FBIO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Fortress Biotech Inc shares
What is Fortress Biotech Inc 52-week high and low stock price?

The 52-week high price of Fortress Biotech Inc (FBIO) is $4.53. The 52-week low price of Fortress Biotech Inc (FBIO) is $1.33.

What is Fortress Biotech Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Fortress Biotech Inc (FBIO) is

What is Fortress Biotech Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Fortress Biotech Inc (FBIO) is 1.94

What is Fortress Biotech Inc dividend yield?

The dividend yield of Fortress Biotech Inc (FBIO) is 0.00%

What is the Market Cap of Fortress Biotech Inc?

The market capitalization of Fortress Biotech Inc (FBIO) is $112.05M

What is Fortress Biotech Inc's stock symbol?

The stock symbol (or ticker) of Fortress Biotech Inc is FBIO

How Can Investors Use Fortress Biotech Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Fortress Biotech Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Fortress Biotech Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Fortress Biotech Inc shares for Indian investors?

When investing in Fortress Biotech Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Fortress Biotech Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Fortress Biotech Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Fortress Biotech Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Fortress Biotech Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top